Heartflow, Inc.
HTFLHealthcareNASDAQHealth Information Services · Last scanned Jul 18, 2026
Scan Results
Daily timeframeHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. With a market capitalization of $2.15B, it sits in mid-cap territory. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Market Cap
$2.15B
Beta
—
P/E (TTM)
—
P/E (Fwd)
-94.12
EPS (TTM)
$-2.96
EPS (Fwd)
$-0.26
ROE
-135.3%
ROA
-16.2%
Cash
$158.3M
Total Debt
$26.3M
Free CF
-$48.7M
52W Change
-17.0%
Annual Financials
Cash vs Debt
Heartflow, Inc. holds $158.3M in cash against $26.3M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$48.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -135.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $87.2M (2023) to $176.0M (2025), reflecting a 102% increase over the period.
With cash comfortably exceeding debt, HTFL has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Heartflow, Inc.'s trajectory.